Serum Triglycerides and Clinical Benefit in Lipid-Lowering Trials

This publication has 10 references indexed in Scilit:

• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
  The Lancet, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1995
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
  JAMA, 1995
• Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
  Circulation, 1992
• Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
  JAMA, 1988
• Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid
  Acta Medica Scandinavica, 1988
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984